Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Obesity lowers risk of death in PE patients

Khan Z et al. CHEST. 2018 Oct. doi: 10.1016/j.chest.2018.08.919

Publish date:: October 12, 2018

Key clinical point: The obesity paradox observed in other chronic conditions held true in this study of patients with pulmonary embolism (PE).

Major finding: Obese PE patients had more risk factors and more severe disease, but an overall mortality of 2.2% vs 3.7% in nonobese PE patients.

Study details: Retrospective analysis of the National Inpatient Sample (NIS) database including almost 2 million individuals with a primary discharge diagnosis of PE.

Disclosures: Study authors had no disclosures.

Read the article.

Citation:

Khan Z et al. CHEST. 2018 Oct. doi: 10.1016/j.chest.2018.08.919

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Thrombosis

DOACs look safe in elective endoscopic procedures,

Lusutrombopag found safe, effective for severe thrombocytopenia in patients with hepatocellular carcinoma,

HOME-PE trial clarifies which pulmonary embolism patients to treat at home,

Aspirin may accelerate cancer progression in older adults,

Low-dose prasugrel preserves efficacy but lowers bleeding in elderly,